Melissa A Fleegal-DeMotta

Angiotensin II Modulates BBB Permeability via Activation of the AT1 Receptor in Brain Endothelial Cells

W. Banks, Melissa A Fleegal-DeMotta, S. Doghu, 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Nitric oxide isoenzymes regulate lipopolysaccharide-enhanced insulin transport across the blood-brain barrier.

W. Banks, M. Erickson, S. Dohgu, 2008, Endocrinology.

Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse p8 model of Alzheimer's disease: effects of anti-amyloid antibody and antisense treatments.

W. Banks, J. Morley, G. Shah, 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by luminal microvessel IL-6 and GM-CSF

W. Banks, S. Dohgu, Melissa A Fleegal-DeMotta, 2011, Journal of Neuroinflammation.

Lipopolysaccharide alters the blood–brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer’s disease

W. Banks, R. Sultana, G. Shah, 2009, Brain, Behavior, and Immunity.

Author ' s personal copy Lipopolysaccharide alters the blood – brain barrier transport of amyloid b protein : A mechanism for inflammation in the progression of Alzheimer ’ s disease

W. Banks, R. Sultana, G. Shah, 2009 .

Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition.

S. M. Robinson, W. Banks, M. Murphy, 2009, Journal of Alzheimer's disease : JAD.

Lipopolysaccharide alters the blood–brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer’s disease

R. Sultana, Laura B. Jaeger, M. Erickson, 2009, Brain, Behavior, and Immunity.